ITMN4077 is a small molecule antiviral compound that inhibits Hepatitis C virus replication. It demonstrates activity in vitro with an EC50 of 2.131 µM against an HCV subgenomic replicon in HuH7 cells, supporting its use in HCV virology and drug discovery research.